MGTX Meiragtx Holdings PLC
Health Care, filed as MEIRAGTX HLDGS PLC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab
In 2026 Q2 James Silverman added to Meiragtx.
Who owns this now
Largest portfolio weights among holders, up to 4.3% (James Silverman, Opaleye Management). Not free-float ownership.
Who owns MGTX
Sorted by value, long equity only, as of 2026 Q2.
| History | |||||
|---|---|---|---|---|---|
| James Silverman, Opaleye Management | Add +67.2% | 3,550,000 | $48M | History |
Insider trades
Open-market buys and sales by MGTX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- None no sales outside a trading plan
- $4.7M sold by 3 insiders under 10b5-1 plans
-
Richard Giroux CFOPlanned sale$557K 56,000 shares at $9.95 6.2% of stakeTraded Oct 20 Filed Oct 20
-
Stuart Naylor Chief Sci Ofcr, OphthalmologyPlanned sale$294K 27,659 shares at $10.64 4.3% of stakeTraded Oct 6 Filed Oct 6
-
Alexandria Forbes CEOPlanned sale$859K 62,000 shares at $13.86 4.5% of stakeTraded Aug 18 Filed Aug 18
-
Richard Giroux CFOPlanned sale$701K 56,000 shares at $12.51 5.8% of stakeTraded Jul 21 Filed Jul 21
-
Stuart Naylor Chief Sci Ofcr, OphthalmologyPlanned sale$409K 27,659 shares at $14.80 4.1% of stakeTraded Jul 7 Filed Jul 7
-
Alexandria Forbes CEOPlanned sale$569K 62,000 shares at $9.17 4.3% of stakeTraded May 19 Filed May 19
-
Richard Giroux CFOPlanned sale$572K 56,000 shares at $10.22 5.4% of stakeTraded Apr 21 Filed Apr 21
-
Stuart Naylor Chief Dev. OfficerPlanned sale$259K 27,661 shares at $9.36 4% of stakeTraded Apr 7 Filed Apr 7
-
Alexandria Forbes CEOPlanned sale$459K 62,000 shares at $7.41 4.1% of stakeTraded Mar 24 Filed Mar 24
-
Richard Giroux CFOPlanned sale$213K 24,000 shares at $8.87 2.8% of stakeTraded Oct 21, 2025 Filed Oct 21, 2025
-
Alexandria Forbes CEOPlanned sale$399K 47,500 shares at $8.39 3.5% of stakeTraded Oct 7, 2025 Filed Oct 7, 2025
Also filed in the last 12 months, not counted as buying or selling: 16 option exercises, 15 share withholdings for taxes, 3 gifts, 1 stock grant, and 1 sale back to the company.
SEC filings
Recent issuer filings from EDGAR, 15 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 1.01,1.02,2.03,3.02,7.01,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 424B5 | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $159.62M | $123.52M | $91.76M |
| Total non-current assets * | $167.12M | $146.23M | $152.67M |
| Total assets | $326.74M | $269.75M | $244.43M |
| Total current liabilities | $67.08M | $60.78M | $122.56M |
| Total non-current liabilities * | $121.49M | $141.14M | $127.67M |
| Total equity | $138.18M | $67.83M | -$5.79M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.